🔎 Trials Near Me

Domov › Akutna limfoblastna levkemija › New Jersey

Klinične študije za Akutna limfoblastna levkemija v New Jersey

11 študij za Akutna limfoblastna levkemija išče udeležence na lokacijah v New Jersey.

Mesta v New Jersey

Uradno besedilo študije (angleško)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Englewood Hospital and Medical Center, Englewood
  • Hackettstown Medical Center, Hackettstown
  • Morristown Medical Center, Morristown
  • in še 6
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 40–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05334069

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Vključevanje udeležencevFaza 1
Starost 12–78 · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT03802695

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • Hackensack University Medical Center, Hackensack
  • Morristown Medical Center, Morristown
  • Jersey Shore Medical Center, Neptune City
  • in še 3
Vključevanje udeležencevFaza 1/2
Do 22 let · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT04726241

A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia

  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
Vključevanje udeležencevFaza 2
Starost 40 in več · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT07400029

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Hackensack University Medical Center, Hackensack
  • Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick
Vključevanje udeležencevOpazovalna študija
Vse starosti · Vsi spoli · Posodobljeno 6. jul. 2026 · NCT01351545

A Study of Revumenib and Mezigdomide in People With Leukemia

  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
Vključevanje udeležencevFaza 1/2
Starost 12 in več · Vsi spoli · Posodobljeno 22. jun. 2026 · NCT07356154

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • Hackensack University Medical Center, Hackensack
Vključevanje udeležencevOpazovalna študija
Vse starosti · Vsi spoli · Posodobljeno 18. maj 2026 · NCT01790152

A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)

  • Ascentage Investigative Site #1064, Hackensack
  • Ascentage Investigative Site #1098, New Brunswick
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 30. apr. 2026 · NCT06051409

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

  • Atlantic Health, Morristown
  • Rutgers Cancer Institute of New Jersey, New Brunswick
Vključevanje udeležencevFaza 1/2
Starost 12 in več · Vsi spoli · Posodobljeno 24. mar. 2026 · NCT04988555

A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)

  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
Vključevanje udeležencevFaza 1
Starost 17 in več · Vsi spoli · Posodobljeno 10. feb. 2026 · NCT06287528

Bright Ideas - CIN Feasibility Study

  • Rutgers Cancer Institute, New Brunswick
Vključevanje udeležencev
Starost 4–18 · Vsi spoli · Posodobljeno 31. jan. 2025 · NCT04929899

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.